ADIPOQ and chronic kidney disease: We did not measure serum adiponectin levels to confirm whether the ADIPOQ rs182052 GG genotype interacted with diabetes to increase CKD risk through serum adiponectin levels or through other mechanisms, and this requires further exploration.